Actively Recruiting
Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy
Led by Federico II University · Updated on 2026-03-30
3000
Participants Needed
1
Research Sites
265 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.
CONDITIONS
Official Title
Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age ≥ 18 years
- Diagnosis of type 2 diabetes mellitus (T2DM)
- Stable clinical conditions
- Outpatient settings
- Ability to understand the study procedures and provide written informed consent.
You will not qualify if you...
- Patients with type 1 diabetes mellitus
- Active participation in interventional studies
- Any condition that may put the patient at risk by participating in the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Federico II University of Naples, Department of Advanced Biomedical Sciences
Naples, Napoli, Italy, 80131
Actively Recruiting
Research Team
P
Pasquale Perrone Filardi
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here